Telerehabilitation of Reduced Physiotherapy Service in SARS-CoV-2 Pandemic Process in Lung Surgery Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Lung Cancer
- Sponsor
- Istanbul Medipol University Hospital
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Major complication rate
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
In this study, providing access to physiotherapy applications by telerehabilitation method and the effectiveness of this application will be examined for patients who have undergone lung surgery in the early postoperative period during the pandemic process in which social isolation continues.
Detailed Description
* Patients who meet the inclusion criteria and agree to participate in the study will be included in the study. * Patients diagnosed with lung cancer and underwent thoracotomy will be randomly divided into Telerehabilitation Group (TGR) and Control (KG) groups. * Before the operation, enlightened and signed consent will be obtained from the cases, the first evaluations of the patients in both groups will be made and the first exercise training will be given to the telerehabilitation group. * The study group will be followed up every day during their hospitalizations and the final tests of both groups will be made before discharge. Long-term follow-up will be carried out in the 1st month and 3rd month after discharge.
Investigators
esra pehlivan
Principal investigator
Saglik Bilimleri Universitesi
Eligibility Criteria
Inclusion Criteria
- •Having a smart phone and capable of making video calls,
- •Planned to be operated with thoracotomy or videothoracoscope,
- •Staged between IA and IIIB with clinical staging,
- •With proven lung tumor (If AC diagnosis is not confirmed after frozen or wedge, the patient will be excluded from the study),
- •Patients with no cardiac disease (ASA II or better) that affects their quality of life.
Exclusion Criteria
- •Having a cardiac disease that affects the quality of life,
- •Serious cognitive problems and presence of psychiatric diseases,
- •Presence of physical limitations (vision, hearing impairment, orthopedic problems).
Outcomes
Primary Outcomes
Major complication rate
Time Frame: Up to 3 months
Major complication rates such as postoperative fever, infection, and hemorrhage will be documented.
Secondary Outcomes
- Visual analog scale(Up to 3 months)
- Diffusion Capacity(Change from baseline to 1 and 3 months)
- Lung V/Q Scintigraphy(Change from baseline to 1 and 3 months)
- Procalcitonin (PCT)(Up to 3 months)
- C-Reactive Protein (CRP)(Up to 3 months)
- Ferritin(Up to 3 months)
- D'dimer test(Up to 3 months)
- Partial Oxigen Pressure (PaO2)(Up to 3 months)
- The six-minute walking test(Up to 3 months)
- Duration of tube thoracostomy drainage(Up to 3 months)
- Forced expiratory volume one second (FEV1)(Up to 3 months)
- Modified Medical Research Council Dyspnea Scale(Up to 3 months)
- Forced vital capacity (FVC)(Up to 3 months)
- Lung Capacities(Change from baseline to 1 and 3 months)
- Lactate dehydrogenase(Up to 3 months)
- Partial Carbon monoxide Pressure (PaCO2)(Up to 3 months)
- Arterial blood oxygen saturation level (SaO2)(Up to 3 months)
- Anxiety inventory(Up to 3 months)